Send us a text

What if you could revolutionize your skincare routine with a pioneering innovation? Join us as we unravel the inspiring journey of Dr. Nicole Hayre, the visionary force behind Cutocin, who transitioned from genetics research to reshape the landscape of dermatology. Her fascinating story takes us from the laboratory to her boutique-style dermatology practice in Northern Virginia, where data-driven decisions ensure the highest standard of patient care. Discover the groundbreaking Cutocin skincare line, which uniquely leverages oxytocin through a botanical ingredient, and celebrate with us as Dr. Hayre shares the triumph of receiving a patent for her innovative work, underscoring her dedication to advancing dermatological care.

A trailblazer in cosmetic dermatology, Dy. Hayre shares her philosophy on life's journey marked by flexibility and openness. Dr. Hayre's joy in connecting with her patients reveals the enriching power of communication and friendliness, making it clear how these interactions enhance her practice and personal growth. With insights from her work at the Cosmetic Dermatology Center in McLean, Virginia, and her involvement with Cutocin, she invites listeners to engage more deeply with others and explore her contributions to the field. Tune in for a deeper understanding of how these two remarkable women continue to shape and inspire the world of dermatology.

#CatalyzeImpact #Cutocin #podcast

Learn More About Cutocin: https://cutocin.com/

View More From IdeagenGlobal: https://www.ideagenglobal.com/

Send us a text

Join us as we unravel the fascinating journey of Thrasyvoulos Karydis, or Thras, the brilliant mind behind DeepCure's technological revolution in drug discovery. From the serene landscapes of Corfu, Greece, to the bustling halls of MIT, Thras's path is a testament to the power of curiosity and innovation. With a robust background in electrical engineering, computer science, and physics, Thras ventured into the biotechnological frontier, merging AI with molecular biology to spearhead groundbreaking advancements in immunology and inflammation treatments. Discover how his transformative experiences at the MIT Media Lab ignited the spark that would become DeepCure, a company at the cutting edge of therapeutic development.

In our conversation, we explore the synergetic power of AI and human expertise in overcoming the traditional constraints of drug design. Thras shares real-life narratives of initial challenges turning into triumphs, illustrating AI's potential to reshape the landscape of drug discovery. Thras discusses DeepCure's ambitious goals, including upcoming clinical trials for DC9476 targeting rheumatoid arthritis. As DeepCure continues to push boundaries with their innovative platform and open-minded approach, find out how they plan to repeatedly design transformative therapeutics and make a lasting impact on patient lives. Don't miss this insightful episode that promises a glimpse into the future of healthcare innovation.

#ideagenglobal #globalpartnerships #deepcure

Thras's LinkedIn: https://www.linkedin.com/in/thkarydis/

Learn more about DeepCure here: https://www.deepcure.ai/

Watch the entire Global Partnerships Summit here: https://www.ideagenglobal.com/2024-global-partnerships-summit

Send us a text

Join us as we unravel the fascinating journey of Thrasyvoulos Karydis, or Thras, the brilliant mind behind DeepCure's technological revolution in drug discovery. From the serene landscapes of Corfu, Greece, to the bustling halls of MIT, Thras's path is a testament to the power of curiosity and innovation. With a robust background in electrical engineering, computer science, and physics, Thras ventured into the biotechnological frontier, merging AI with molecular biology to spearhead groundbreaking advancements in immunology and inflammation treatments. Discover how his transformative experiences at the MIT Media Lab ignited the spark that would become DeepCure, a company at the cutting edge of therapeutic development.

In our conversation, we explore the synergetic power of AI and human expertise in overcoming the traditional constraints of drug design. Thras shares real-life narratives of initial challenges turning into triumphs, illustrating AI's potential to reshape the landscape of drug discovery. Thras discusses DeepCure's ambitious goals, including upcoming clinical trials for DC9476 targeting rheumatoid arthritis. As DeepCure continues to push boundaries with its innovative platform and open-minded approach, find out how it plans to repeatedly design transformative therapeutics and make a lasting impact on patient lives. Don't miss this insightful episode that promises a glimpse into the future of healthcare innovation.

#ideagenglobal #globalpartnerships #summerdiscovery #thenewschool

Esteban's LinkedIn: https://www.linkedin.com/in/estebanolivares/
Amit's LinkedIn: https://www.linkedin.com/in/amitshahnyc/

Learn more about Summer Discovery here: https://www.summerdiscovery.com/
Learn more about The New School here: https://www.newschool.edu/parsons/

Watch the entire Global Partnerships Summit here: https://www.ideagenglobal.com/2024-global-partnerships-summit